Major Companies for Zebrafish for Biotech Market: Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide, Pentagrit, Evotec, Aurigene Pharmaceutical Services, ikanbiotech, Bioreperia, Hangzhou Hunter Biotechnology Co., Ltd., YSY BIOTECH, Eze-Rinka, INVENesis, FEIFAN TEST, Charles River Laboratories.
Global Zebrafish for Biotech Market Size was estimated at USD 183.6 million in 2022 and is projected to reach USD 273.992647049943 million by 2028, exhibiting a CAGR of 6.9% during the forecast period.
Global Zebrafish for Biotech Market Overview And Scope:
The Global Zebrafish for Biotech Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Zebrafish for Biotech utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2024 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Zebrafish for Biotech Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Zebrafish for Biotech portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Zebrafish for Biotech market.
Global Zebrafish for Biotech Market Segmentation
By Type, Zebrafish for Biotech market has been segmented into:
Toxicity Testing Services
Transgenesis and Gene Editing Services
Disease Models
Others
By Application, Zebrafish for Biotech market has been segmented into:
Biotechnology Companies
Research Institutes
Regional Analysis of Zebrafish for Biotech Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Zebrafish for Biotech Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Zebrafish for Biotech market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Zebrafish for Biotech market.
Major Companies Covered in Zebrafish for Biotech market are:
Shanghai Model Organisms Center
Inc.
ZeClinics
InVivo Biosystems
Biobide
Pentagrit
Evotec
Aurigene Pharmaceutical Services
ikanbiotech
Bioreperia
Hangzhou Hunter Biotechnology Co.
Ltd.
YSY BIOTECH
Eze-Rinka
INVENesis
FEIFAN TEST
Charles River Laboratories
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Zebrafish for Biotech Market by Type
5.1 Zebrafish for Biotech Market Overview Snapshot and Growth Engine
5.2 Zebrafish for Biotech Market Overview
5.3 Toxicity Testing Services
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Toxicity Testing Services: Geographic Segmentation
5.4 Transgenesis and Gene Editing Services
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Transgenesis and Gene Editing Services: Geographic Segmentation
5.5 Disease Models
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Disease Models: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: Zebrafish for Biotech Market by Application
6.1 Zebrafish for Biotech Market Overview Snapshot and Growth Engine
6.2 Zebrafish for Biotech Market Overview
6.3 Biotechnology Companies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Biotechnology Companies: Geographic Segmentation
6.4 Research Institutes
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Research Institutes: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Zebrafish for Biotech Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Zebrafish for Biotech Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Zebrafish for Biotech Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 SHANGHAI MODEL ORGANISMS CENTER
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 INC.
7.4 ZECLINICS
7.5 INVIVO BIOSYSTEMS
7.6 BIOBIDE
7.7 PENTAGRIT
7.8 EVOTEC
7.9 AURIGENE PHARMACEUTICAL SERVICES
7.10 IKANBIOTECH
7.11 BIOREPERIA
7.12 HANGZHOU HUNTER BIOTECHNOLOGY CO.
7.13 LTD.
7.14 YSY BIOTECH
7.15 EZE-RINKA
7.16 INVENESIS
7.17 FEIFAN TEST
7.18 CHARLES RIVER LABORATORIES
Chapter 8: Global Zebrafish for Biotech Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Toxicity Testing Services
8.2.2 Transgenesis and Gene Editing Services
8.2.3 Disease Models
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Biotechnology Companies
8.3.2 Research Institutes
Chapter 9: North America Zebrafish for Biotech Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Toxicity Testing Services
9.4.2 Transgenesis and Gene Editing Services
9.4.3 Disease Models
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Biotechnology Companies
9.5.2 Research Institutes
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Zebrafish for Biotech Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Toxicity Testing Services
10.4.2 Transgenesis and Gene Editing Services
10.4.3 Disease Models
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Biotechnology Companies
10.5.2 Research Institutes
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Zebrafish for Biotech Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Toxicity Testing Services
11.4.2 Transgenesis and Gene Editing Services
11.4.3 Disease Models
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Biotechnology Companies
11.5.2 Research Institutes
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Zebrafish for Biotech Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Toxicity Testing Services
12.4.2 Transgenesis and Gene Editing Services
12.4.3 Disease Models
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Biotechnology Companies
12.5.2 Research Institutes
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Zebrafish for Biotech Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Toxicity Testing Services
13.4.2 Transgenesis and Gene Editing Services
13.4.3 Disease Models
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Biotechnology Companies
13.5.2 Research Institutes
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Zebrafish for Biotech Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Toxicity Testing Services
14.4.2 Transgenesis and Gene Editing Services
14.4.3 Disease Models
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Biotechnology Companies
14.5.2 Research Institutes
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Zebrafish for Biotech Scope:
|
Report Data
|
Zebrafish for Biotech Market
|
|
Zebrafish for Biotech Market Size in 2025
|
USD XX million
|
|
Zebrafish for Biotech CAGR 2025 - 2032
|
XX%
|
|
Zebrafish for Biotech Base Year
|
2024
|
|
Zebrafish for Biotech Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide, Pentagrit, Evotec, Aurigene Pharmaceutical Services, ikanbiotech, Bioreperia, Hangzhou Hunter Biotechnology Co., Ltd., YSY BIOTECH, Eze-Rinka, INVENesis, FEIFAN TEST, Charles River Laboratories.
|
|
Key Segments
|
By Type
Toxicity Testing Services
Transgenesis and Gene Editing Services
Disease Models
Others
By Applications
Biotechnology Companies
Research Institutes
|
